U.S. Personal Products Stock News

Wondering if Lockheed Martin's current share price reflects its true worth, or if the market is getting ahead of itself? This article is going to walk you through what the numbers actually say about value. Lockheed Martin closed at US$658.26 recently, with returns of 0.9% over 7 days, 11.4% over 30 days, 32.4% year to date and 53.8% over the past year. These figures have many investors asking whether the stock's risk and reward are still in balance. Recent headlines have focused on Lockheed...

Why Abbott Laboratories (ABT) is Back on Investors’ Radar Abbott Laboratories (ABT) is drawing fresh attention after recent share price moves, with the stock roughly flat over the past week but showing a gain over the past month and weaker returns over the past year. See our latest analysis for Abbott Laboratories. At a share price of US$112.21, Abbott’s recent 4.46% 1 month share price return contrasts with its weaker year to date share price performance and a 15.27% 1 year total shareholder...

If you are looking at AMETEK and wondering whether the current price really reflects its underlying worth, you are not alone. The stock last closed at US$233.51, with returns of 1.6% over 7 days, 5.8% over 30 days, 11.7% year to date, 26.3% over 1 year, 69.0% over 3 years, and 104.5% over 5 years. This naturally raises questions about how much future potential or risk is already priced in. Recent coverage around AMETEK has focused on its role in the capital goods space and how investors are...

Targa Resources Corp. recently reported 2025 results showing revenue of US$17.03 billion and net income of US$1.92 billion, while also outlining extensive new gas processing and NGL infrastructure projects across the Permian and Gulf Coast that are scheduled to come online through 2028. The company coupled this with a planned 25% increase in its 2026 annual common dividend per share to US$5.00, underpinned by record volumes, expanding processing and fractionation capacity, and ongoing share...

Pool (POOL) has attracted investor attention after recent share price moves, with the stock showing a 1 day gain of 1.49% but negative returns over the past week and month. See our latest analysis for Pool. That 1 day share price gain sits against weaker momentum, with a 7 day share price return of 16.63% and a 30 day share price return of 16.38%. The 1 year total shareholder return of 34.66% and 5 year total shareholder return of 29.70% point to sustained pressure rather than a recent...

General Motors (GM) has put fresh capital behind its long game in trucks and SUVs, outlining nearly US$1.8b for a next generation small block V8, along with more than US$63m for its Oshawa Assembly plant. See our latest analysis for General Motors. Those new truck and SUV investments sit against a share price of US$81.51, with a 90 day share price return of 14.8% and a 1 year total shareholder return of 77.9%. This suggests momentum has been building as GM balances recalls, inventory...

Blackstone Mortgage Trust (BXMT) just paired a change in its finance leadership with fresh earnings and a completed share repurchase program, giving investors several new data points to assess the stock’s risk and income profile. See our latest analysis for Blackstone Mortgage Trust. At a share price of $19.52, Blackstone Mortgage Trust has seen a 1-day share price return of 1.24%, a 30-day share price return of 2.52%, and a 1-year total shareholder return of 5.28%. These developments around...

Earlier this week, Roth Capital Markets analyst Scott Searle reaffirmed a positive stance on Arlo Technologies, emphasizing the company’s privacy-focused culture, upcoming fourth-quarter results, and the launch of its Series 6 products as potential support for subscription and services revenue. The analyst’s view positions Arlo’s privacy differentiation, especially versus a rival facing scrutiny, as a potential lever to deepen partnerships with firms such as ADT and Allstate and strengthen...

Madrigal Pharmaceuticals (MDGL) is back in focus after reporting full-year 2025 results, combining nearly US$1 billion in Rezdiffra sales with a net loss of US$288.28 million and an improving per-share loss. See our latest analysis for Madrigal Pharmaceuticals. The recent full year 2025 update comes after a sharp pullback in the share price, with a 30 day share price return of 9.46% and a 90 day share price return of a 26.52% decline. However, longer term total shareholder returns of 35.04%...

Earlier this month, Helix Energy Solutions Group extended its long-running subsea well intervention alliance by nine months to October 5, 2026, while also preparing to report quarterly earnings on February 23, 2026 amid growing attention to its operational progress. Investor focus has intensified as Helix pairs a fresh multi-year UK North Sea plug and abandonment award with an approaching leadership transition following CEO Owen Kratz’s planned retirement. Next, we’ll examine how the new UK...

Toyota has expanded its partnership with Joby Aviation, offering hands-on support based on the Toyota Production System and committing additional funding. Joby reports progress toward FAA certification for its electric air taxi and is adding new manufacturing capacity through facilities and partner agreements. The combination of operational help, capital, and certification progress is aimed at moving NYSE:JOBY closer to commercial service. Joby Aviation, trading on the NYSE under the ticker...

Expand Energy Corporation recently reported past fourth-quarter and full-year 2025 results, with revenue of US$3,272 million and US$12.12 billion respectively, net income of US$553 million and US$1.82 billion, strong earnings per share, and production of about 7.40 Bcfe/d in the quarter and 7.18 Bcfe/d for the year. The company also issued 2026 production guidance of roughly 7.5 Bcfe/d, affirmed its US$0.575 per-share base dividend for March 2026, completed a US$99.99 million buyback...

Wondering if Flowserve at around US$88.94 is priced for opportunity or already reflects the story? This article focuses on what the current share price may be implying about the company’s value. The stock has seen a small 0.8% decline over the last 7 days, while its returns over 30 days, year to date, 1 year, 3 years, and 5 years stand at 14.2%, 25.7%, 63.0%, 168.6%, and 166.6% respectively. These moves may have shifted how investors think about its potential and risk. These moves sit...

nVent Electric (NYSE:NVT) appointed Mellinda Devese as Executive Vice President and Chief Supply Chain Officer. Devese joins nVent from GE HealthCare, where she held multiple global supply chain leadership roles. Her appointment signals an increased focus on supply chain performance across nVent’s global operations. nVent Electric, listed on the NYSE under ticker NVT, focuses on electrical connection and protection solutions across industrial, commercial, and infrastructure markets. Supply...

IHS Holding (NYSE:IHS) has agreed to be acquired by MTN Group in an all cash transaction. The deal will take IHS private and is expected to result in its delisting from the NYSE. IHS is also exiting Latin America through the sale of its tower operations in the region to Macquarie Asset Management. These moves collectively reshape the company’s ownership structure, business model, and geographic footprint. IHS Holding runs telecom tower infrastructure, which is central to mobile connectivity...

Recent commentary on Greenbrier Companies (GBX) has focused on two years of declining unit sales, tighter supply chain competition, high production costs that have compressed gross margins to 14%, and negative free cash flow that has heightened investor scrutiny. See our latest analysis for Greenbrier Companies. Against those headwinds, the share price has shown strong momentum, with a 16.21% 1 month share price return, a 36.01% 3 month share price return, and a 106.10% 3 year total...

If you are wondering whether Federal Agricultural Mortgage is starting to look like value after its recent pullback, this article will walk through what the current share price might be implying about the company. The stock last closed at US$149.46, with a 14.1% decline over 7 days, a 12.7% decline over 30 days, a 15.3% decline year to date, and a 25.8% decline over the past year, while the 3 year and 5 year returns sit at 15.9% and 103.1% respectively. Recent coverage has focused on how...

What recent performance says about Immunome (IMNM) Immunome (IMNM) has been on many biotech watchlists after a mixed stretch in its share price, with a decline over the past month but a gain across the past 3 months and strong 1 year and 3 year total returns. See our latest analysis for Immunome. Short term, the 30 day share price return of 16.89% decline and recent weekly softness suggest fading momentum. However, the 1 year and 3 year total shareholder returns remain very strong compared...

Kohl's (KSS) is back in focus after recent trading left the share price at US$18.78, with a 1-day return of a 2.49% decline and a 7-day return of a 5.39% decline. See our latest analysis for Kohl's. While the recent 7 day share price return of a 5.39% decline, alongside a 1 day drop and year to date weakness, points to fading short term momentum, the 90 day share price return of 19.39% and 1 year total shareholder return of 62.92% show a very different longer term picture that investors are...

In recent days, Reddit reported revenue growth of 69.7% year on year, surpassing analyst forecasts by 8.7% and lifting daily active users to 52.5 million, while leadership outlined a focus on sharper execution, global expansion, and product innovation rooted in real conversations. This combination of stronger-than-expected financial performance and expanding user engagement highlights how Reddit’s community-driven model is being translated into a more scalable, monetizable platform for...

GE Vernova at a Glance: What Recent Returns Signal for Investors GE Vernova (GEV) has drawn increased investor attention after a recent share price move, with the stock showing a 0.5% decline over the past day but gains over the week, month, and past 3 months. Those returns sit alongside reported annual revenue of US$38.1b and net income of US$4.9b, giving investors a sense of the company’s current earnings base as they assess whether recent price action aligns with fundamentals. See our...

Many investors are asking whether Welltower's current share price is aligned with its underlying value, or whether expectations have moved ahead of the fundamentals. The stock last closed at US$208.19, with a 1 year return of 42.6% and a 3 year return that is very large at around triple the starting point. This kind of performance can change how the market views both its growth potential and its risk profile. Recent headlines around Welltower have focused on portfolio activity, capital...

Viking Therapeutics (VKTX) is back in focus after reporting a full year 2025 net loss of US$359.64 million and a wider basic loss per share, while advancing weight loss candidate VK2735 through late stage trials. See our latest analysis for Viking Therapeutics. At a share price of US$31.03, Viking Therapeutics has a 7 day share price return of 7.00%, while the 90 day share price return of 12.49% and year to date share price return of 12.39% suggest momentum has cooled compared with its very...

Wondering if GXO Logistics is still good value after its recent run, or if you might be late to the story? This article is aimed squarely at that question. The share price recently closed at US$65.59, with returns of 0.1% over 7 days, 14.2% over 30 days, 20.8% year to date, and 66.9% over the past year. These figures naturally raise questions about growth potential and changing risk perceptions. Recent coverage has focused on GXO Logistics' position in outsourced logistics and warehouse...